Has Paul Anthony, MD received payments from drug or device companies?

Yes. Drug and device makers reported $90,718 in general payments to Paul Anthony, MD across 112 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Anthony, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Anthony, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Anthony, MD

Infectious Disease · Hartford, CTNPI 1912156597

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $78,495 of the $90,718 with a category attached, or 86.5%. Gilead accounts for 99.4% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $30,880, 2.4 times the $12,774 reported in 2019. Among infectious disease clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,718in general payments, 2019–2025

Across 112 payments — averaging $809.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$90K
Theratechnologies Inc.$239
AstraZeneca$125
Viiv Healthcare Company$124
Novo Nordisk$18

What the payments were for

Consulting fees$3,1503%
Speaking & faculty fees$78,49587%
Travel & lodging$5,5286%
Food & beverage$3,5464%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	107	$90,213
Theratechnologies Inc.	2	$239
AstraZeneca	1	$125
Viiv Healthcare Company	1	$124
Novo Nordisk	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Biktarvy$41,133
Epclusa$128
AIRSUPRA$125
DOVATO$124
EGRIFTA$120
EGRIFTA SV$119

How this compares

$90,718 in reported general payments places this provider in the 95th percentile of 159 infectious disease providers in Connecticut.

See all infectious disease providers in Connecticut →

Medicare billing

Part B allowed, 2024

$27,175

Medicare patients

Services billed

265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Hartford

Kathryn GoldmanHartford$4K
Robert LevitzHartford$3K
Lauren IbrahimHartford$619
Harry ConteHartford$617
Faiqa CheemaHartford$426
Zane SaulStratford$513K
Stephen ScholandMeriden$428K
Onyema OgbuaguNew Haven$412K
David RubinNorwalk$397K
Steven SchnittmanWest Haven$363K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →